Insidersinvested$26.5mI'm ashareholdermyselfWe will openupinternationalsites forMino-Lok trialThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"We willhaveexclusivityThere are noFDAapproveddrugs to treathemorrhoidsWe haveenough cashto go wellinto 2023Mino-WrapI/ONTAKis our leadassetI won't diluteshareholdersWe had aphase 2btrial with100%efficacyI/ONTAK'spotentialmarket is>$300mOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAKwas thebest deal Iever madeMino-Lokpotentialmarket>$1BI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Hemorrhoidsis a $2BmarketMyron Holubiakand I founded aprivatecompany in2013Not manycompaniesthis size with2 late stageassetsWe expect tofinish theMino-Loktrial this yearAn actualiMSCupdateOnly biotechwith 2 Myron'son theleadershipteamWe intendto submita BLA in2H 2022Mino-Lokis our leadassetInsidersinvested$26.5mI'm ashareholdermyselfWe will openupinternationalsites forMino-Lok trialThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"We willhaveexclusivityThere are noFDAapproveddrugs to treathemorrhoidsWe haveenough cashto go wellinto 2023Mino-WrapI/ONTAKis our leadassetI won't diluteshareholdersWe had aphase 2btrial with100%efficacyI/ONTAK'spotentialmarket is>$300mOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAKwas thebest deal Iever madeMino-Lokpotentialmarket>$1BI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Hemorrhoidsis a $2BmarketMyron Holubiakand I founded aprivatecompany in2013Not manycompaniesthis size with2 late stageassetsWe expect tofinish theMino-Loktrial this yearAn actualiMSCupdateOnly biotechwith 2 Myron'son theleadershipteamWe intendto submita BLA in2H 2022Mino-Lokis our leadasset

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Insiders invested $26.5m
  2. I'm a shareholder myself
  3. We will open up international sites for Mino-Lok trial
  4. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  5. We will have exclusivity
  6. There are no FDA approved drugs to treat hemorrhoids
  7. We have enough cash to go well into 2023
  8. Mino-Wrap
  9. I/ONTAK is our lead asset
  10. I won't dilute shareholders
  11. We had a phase 2b trial with 100% efficacy
  12. I/ONTAK's potential market is >$300m
  13. Our Halo-Lido trial will have final patient by end of 2022
  14. I/ONTAK was the best deal I ever made
  15. Mino-Lok potential market >$1B
  16. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  17. Hemorrhoids is a $2B market
  18. Myron Holubiak and I founded a private company in 2013
  19. Not many companies this size with 2 late stage assets
  20. We expect to finish the Mino-Lok trial this year
  21. An actual iMSC update
  22. Only biotech with 2 Myron's on the leadership team
  23. We intend to submit a BLA in 2H 2022
  24. Mino-Lok is our lead asset